Cephalexin
Surgical Site Infection in Obese Women Undergoing C-section
University of CincinnatiSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Surgical Site Infection in Obese Women Undergoing C-section cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
METRONIDAZOLE University of Cincinnati | N/A | D |
Same molecule, other indications
Cephalexin is also rated in:
methicillin-susceptible staphylococcus aureus infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →methicillin-resistant staphylococcus aureus infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →